Commerzbank Aktiengesellschaft FI increased its holdings in MetLife, Inc. (NYSE:MET – Free Report) by 0.7% in the 4th quarter, Holdings Channel reports. The institutional investor owned 51,743 shares of the financial services provider’s stock after purchasing an additional 383 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in MetLife were worth $4,218,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also bought and sold shares of the company. Swedbank AB grew its position in shares of MetLife by 5.3% in the third quarter. Swedbank AB now owns 1,970,163 shares of the financial services provider’s stock valued at $162,499,000 after purchasing an additional 99,328 shares in the last quarter. Farther Finance Advisors LLC boosted its stake in MetLife by 19.6% in the 3rd quarter. Farther Finance Advisors LLC now owns 10,840 shares of the financial services provider’s stock worth $894,000 after purchasing an additional 1,774 shares during the period. Chicago Partners Investment Group LLC purchased a new position in MetLife during the 3rd quarter valued at about $233,000. Carmichael Hill & Associates Inc. increased its position in shares of MetLife by 131.9% during the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after buying an additional 186 shares during the period. Finally, Robeco Institutional Asset Management B.V. lifted its holdings in shares of MetLife by 18.6% in the third quarter. Robeco Institutional Asset Management B.V. now owns 186,361 shares of the financial services provider’s stock worth $15,371,000 after buying an additional 29,163 shares in the last quarter. 94.99% of the stock is currently owned by hedge funds and other institutional investors.
MetLife Price Performance
MET opened at $85.60 on Tuesday. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. The stock has a market capitalization of $58.31 billion, a P/E ratio of 14.34, a PEG ratio of 0.65 and a beta of 1.07. The stock has a 50-day moving average price of $83.73 and a 200-day moving average price of $82.08. MetLife, Inc. has a 12-month low of $67.30 and a 12-month high of $89.05.
MetLife Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 2.55%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife’s dividend payout ratio is currently 36.52%.
Wall Street Analyst Weigh In
Several equities analysts recently commented on the stock. StockNews.com cut shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Keefe, Bruyette & Woods reduced their price target on shares of MetLife from $100.00 to $98.00 and set an “outperform” rating for the company in a research report on Wednesday, February 12th. Morgan Stanley increased their price objective on MetLife from $101.00 to $109.00 and gave the stock an “overweight” rating in a research report on Friday. Wells Fargo & Company boosted their target price on MetLife from $92.00 to $97.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 19th. Finally, JPMorgan Chase & Co. upped their target price on MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 7th. Two equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $94.58.
Check Out Our Latest Research Report on MET
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
- Five stocks we like better than MetLife
- Investing in Commodities: What Are They? How to Invest in Them
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- How to Plot Fibonacci Price Inflection Levels
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.